NYX-2925, CAS [[2012536-16-0]]

Product Overview

• Article Name: NYX-2925, CAS [[2012536-16-0]]
• Biozol Catalog Number: MCE-HY-135741
• Supplier Catalog Number: HY-135741
• Alternative Catalog Number: MCE-HY-135741-50MG,MCE-HY-135741-1MG,MCE-HY-135741-10MG,MCE-HY-135741-100MG,MCE-HY-135741-10MMX1ML,MCE-HY-135741-25MG,MCE-HY-135741-5MG
• Manufacturer: MedchemExpress
• Category: Biochemikalien

Product Description

NYX-2925 is an orally active NMDAR modulator. NYX-2925 restores levels of activated Src and Src phosphorylation sites on GluN2A and GluN2B in the mPFC. NYX-2925 shows no effect on CAMKII, and any addictive or sedative/ataxic side effects. NYX-2925 can be used for research of a variety of NMDA receptor-mediated central nervous system disorders[1][2].

Product Properties

• Molecular Weight: 297.35
• Purity: 98.77
• CAS Number: [2012536-16-0]
• Formula: C14H23N3O4
• Target: iGluR

Application Notes

• Application Notes: MCE Product type: Reference compound